Frequency, Risk Factors and Survival Associated with an Intrasubsegmental Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma

Background In the treatment of hepatocellular carcinoma (HCC), hepatic resection has the advantage over radiofrequency ablation (RFA) in terms of systematic removal of a hepatic segment. Methods We enrolled 303 consecutive patients of a single naïve HCC that had been treated by RFA at The University of Tokyo Hospital from 1999 to 2004. Recurrence was categorized as either intra- or extra-subsegmental as according to the Couinaud's segment of the original nodule. To assess the relationship between the subsegments of the original and recurrent nodules, we calculated the kappa coefficient. We assessed the risk factors for intra- and extra-subsegmental recurrence independently using univariate and multivariate Cox proportional hazard regression. We also assessed the impact of the mode of recurrence on the survival outcome. Results During the follow-up period, 201 patients in our cohort showed tumor recurrence distributed in a total of 340 subsegments. Recurrence was categorized as exclusively intra-subsegmental, exclusively extra-subsegmental, and simultaneously intra- and extra-subsegmental in 40 (20%), 110 (55%), and 51 (25%) patients, respectively. The kappa coefficient was measured at 0.135 (95% CI, 0.079–0.190; P<0.001). Multivariate analysis revealed that of the tumor size, AFP value and platelet count were all risk factors for both intra- and extra-subsegmental recurrence. Of the patients in whom recurrent HCC was found to be exclusively intra-subsegmental, extra-subsegmental, and simultaneously intra- and extra-subsegmental, 37 (92.5%), 99 (90.8%) and 42 (82.3%), respectively, were treated using RFA. The survival outcomes after recurrence were similar between patients with an exclusively intra- or extra-subsegmental recurrence. Conclusions The effectiveness of systematic subsegmentectomy may be limited in the patients with both HCC and chronic liver disease who frequently undergo multi-focal tumor recurrence.

[1]  M. Makuuchi,et al.  Ultrasonically guided subsegmentectomy. , 1985, Surgery, gynecology & obstetrics.

[2]  M. Makuuchi,et al.  Accurate preoperative evaluation of liver mass lesions without fine‐needle biopsy , 1999, Hepatology.

[3]  M. Olschewski,et al.  Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma , 1999, The Lancet.

[4]  W. Lau,et al.  Partial Hepatectomy With Wide Versus Narrow Resection Margin for Solitary Hepatocellular Carcinoma: A Prospective Randomized Trial , 2007, Annals of surgery.

[5]  Ding‐Shinn Chen,et al.  Percutaneous Ethanol Injection Versus Surgical Resection for the Treatment of Small Hepatocellular Carcinoma: A Prospective Study , 2005, Annals of surgery.

[6]  O. Garden,et al.  Segmental Liver Resection Using Ultrasound‐Guided Selective Portal Venous Occlusion , 1989, Annals of surgery.

[7]  H. Müller,et al.  Hazard rate estimation under random censoring with varying kernels and bandwidths. , 1994, Biometrics.

[8]  R. Poon,et al.  Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. , 1999, Annals of surgery.

[9]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[10]  L. Mariani,et al.  Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. , 2009, The Lancet. Oncology.

[11]  F. Garbagnati,et al.  Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. , 1996, AJR. American journal of roentgenology.

[12]  N. Nagasue,et al.  Repeat hepatectomy for recurrent hepatocellular carcinoma , 1996, The British journal of surgery.

[13]  Y. Shiratori,et al.  Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus—An analysis of 236 consecutive patients with a single lesion , 2000, Hepatology.

[14]  T. Kawabe,et al.  Ablation therapy in containing extension of hepatocellular carcinoma: A simulative analysis of dropout from the waiting list for liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  J. Bruix,et al.  Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. , 1996, Annals of surgery.

[16]  Liver Cancer Study Group of Japan.  The general rules for the clinical and pathological study of primary liver cancer , 2006, The Japanese journal of surgery.

[17]  O. Farges,et al.  Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. , 2002, Surgery.

[18]  R. Romanelli,et al.  Hepatocellular carcinoma and viral cirrhosis. , 1994, Hepatology.

[19]  S. Kawasaki,et al.  Prognostic significance of anatomical resection and des‐γ‐carboxy prothrombin in patients with hepatocellular carcinoma , 1999, The British journal of surgery.

[20]  E. Vicaut,et al.  Radiofrequency ablation of hepatocellular carcinoma: Long‐term results and prognostic factors in 235 Western patients with cirrhosis , 2009, Hepatology.

[21]  Jacob Cohen.  A Coefficient of Agreement for Nominal Scales , 1960 .

[22]  M. Nagao,et al.  Repeat liver resection for hepatocellular carcinoma. , 2001, Journal of the American College of Surgeons.

[23]  H. Eguchi,et al.  Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves. , 2000, Archives of surgery.

[24]  Noriaki Tanaka,et al.  Radiofrequency ablation for hepatocellular carcinoma , 2014 .

[25]  K. Chayama,et al.  Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma , 1993, Cancer.

[26]  D. Geller,et al.  Radiofrequency Ablation of Hepatocellular Carcinoma , 2009 .

[27]  L Solbiati,et al.  Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. , 1999, Radiology.

[28]  M. Makuuchi,et al.  Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey , 2004, Cancer.

[29]  Luigi Solbiati,et al.  Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? , 2007, Hepatology.

[30]  Steven A. Curley,et al.  Radiofrequency Ablation of Hepatocellular Cancer in 110 Patients With Cirrhosis , 2000, Annals of surgery.

[31]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[32]  M. Omata,et al.  Combination therapy of intraarterial 5‐fluorouracil and systemic interferon‐alpha for advanced hepatocellular carcinoma with portal venous invasion , 2006, Cancer.

[33]  W. Lau,et al.  A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.

[34]  M. Ebara,et al.  Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients , 1990, Journal of gastroenterology and hepatology.

[35]  L. Mariani,et al.  Prevention of hepatocellular carcinoma recurrence with alpha‐interferon after liver resection in HCV cirrhosis , 2006, Hepatology.

[36]  M. Makuuchi,et al.  Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. , 2008, Surgery.

[37]  W. Lau,et al.  Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma: A Retrospective Study , 2008, Annals of Surgical Oncology.

[38]  Shinpei Sato,et al.  Percutaneous radiofrequency ablation for hepatocellular carcinoma , 2005, Cancer.

[39]  T. Livraghi,et al.  Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. , 1995, Radiology.

[40]  A. Terano,et al.  Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. , 1993, AJR. American journal of roentgenology.

[41]  Masatoshi Tanaka,et al.  Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[42]  M. Makuuchi,et al.  Radiation therapy for portal venous invasion by hepatocellular carcinoma. , 2005, World journal of gastroenterology.

[43]  V. Paradis,et al.  Underestimation of the influence of satellite nodules as a risk factor for post‐transplantation recurrence in patients with small hepatocellular carcinoma , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[44]  M. Makuuchi,et al.  Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma , 2005, Annals of surgery.

[45]  T. Kawabe,et al.  Radiofrequency ablation for hepatocellular carcinoma in so‐called high‐risk locations , 2006, Hepatology.

[46]  S. Kawasaki,et al.  Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. , 2003, Journal of hepatology.

[47]  Toshihito Seki,et al.  Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma , 1999, Cancer.